COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,686 Articles (22,913 medRxiv, 8,773 bioRxiv)

Most recent first Previous |  Page 1794: Articles 17931-17940  | Next

Impact of COVID-19 pre-test probability on positive predictive value of high cycle threshold SARS-CoV-2 real-time reverse transcription PCR test results
Gubbay, J. B., Rilkoff, H., Kristjanson, H. L., Forbes, J. D., Murti, M., Eshaghi, A., Broukhanski, G., Corbeil, A., Fittipaldi, N., Hopkins, J., Kristjanson, E., Kus, J. V., Macdonald, L., Majury, A., Mallo, G. V., Mazzulli, T., Melano, R. G., Olsha, R., Perusini, S. J., Tran, V., Allen, V. G., Patel, S. N.
10.1101/2021.03.02.21252768 — Posted: 2021-03-03
Genomics and epidemiology of a novel SARS-CoV-2 lineage in Manaus, Brazil
Faria, N. R., Mellan, T. A., Whittaker, C., Claro, I. M., da Silva Candido, D., Mishra, S., Crispim, M. A. E., Sales, F. C. d. S., Hawryluk, I., McCrone, J. T., Hulswit, R. J. G., Franco, L. A. M., Ramundo, M. S., de Jesus, J. G., Andrade, P. S., Coletti, T. d. M., Ferreira, G. M., da Silva, C. A. M., Manuli, E. R., Pereira, R. H. M., Peixoto, P. S., Kraemer, M. U., Gaburo, N., Camilo, C. d. C., Hoeltgebaum, H., Souza, W. M., Rocha, E. C., de Souza, L. M., de Pinho, M. C., Araujo, L. J., Malta, F. S. V., de Lima, A. B., Silva, J. d. P., Zauli, D. A. G., Ferreira, A. C. d. S., Schnekenberg, R.
10.1101/2021.02.26.21252554 — Posted: 2021-03-03 Discussion: Offsite
Comparative analysis of codon usage patterns in SARS-CoV-2, its mutants and other respiratory viruses
Tyagi, N., Sardar, R., Gupta, D.
10.1101/2021.03.03.433699 — Posted: 2021-03-03
Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell epitope mapping
Schreibing, F., Hannani, M., Ticconi, F., Fewings, E., Nagai, J. S., Begemann, M., Kuppe, C., Kurth, I., Kranz, J., Frank, D., Anslinger, T. M., Ziegler, P., Kraus, T., Enczmann, J., Balz, V., Windhofer, F., Balfanz, P., Kurts, C., Marx, G., Marx, N., Dreher, M., Schneider, R. K., Saez-Rodriguez, J., Costa Filho, I. G., Kramann, R.
10.1101/2021.03.03.432690 — Posted: 2021-03-03
Maturation signatures of conventional dendritic cells in COVID-19 reflect direct viral sensing
Marongiu, L., Protti, G., Facchini, F. A., Valache, M., Mingozzi, F., Ranzani, V., Putignano, A. R., Salviati, L., Bevilacqua, V., Curti, S., Crosti, M., D'Angio, M., Bettini, L. R., Biondi, A., Nespoli, L., Tamini, N., Mancini, N., Clementi, N., Abrignani, S., Spreafico, R., Granucci, F.
10.1101/2021.03.03.433597 — Posted: 2021-03-03
Identification and quantification of SARS-CoV-2 leader subgenomic mRNA gene junctions in nasopharyngeal samples shows phasic transcription in animal models of COVID-19 and aberrant pattens in humans
Penrice-Randal, R., Goldswain, H., Prince, T., Randle, N., Salguero, J., Tree, J., Vamos, E., Nelson, C., ISARIC-4C Investigators, , COG-UK Consortium, , Stewart, J. P., Matthews, D. A., Carroll, M., Darby, A., Hiscox, J. A.
10.1101/2021.03.03.433753 — Posted: 2021-03-03
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice
Lai, C.-Y., To, A., Wong, T. A. S., Lieberman, M. M., Clements, D. E., Senda, J. T., Ball, A. H., Pessaint, L., Andersen, H., Donini, O., Lehrer, A. T.
10.1101/2021.03.02.433614 — Posted: 2021-03-03
Altered Sub-Genomic RNA Expression in SARS-CoV-2 B.1.1.7 Infections
Parker, M. D., Lindsey, B. B., Shah, D. R., Hsu, S., Keeley, A. J., Partridge, D. G., Leary, S., Cope, A., State, A., Johnson, K., Ali, N., Raghei, R., Heffer, J., Smith, N., Zhang, P., Gallis, M., Louka, S. F., Whiteley, M., Foulkes, B. H., Christou, S., Wolverson, P., Pohare, M., Hansford, S. E., Green, L. R., Evans, C., Raza, M., Wang, D., Gaudieri, S., Mallal, S., The COVID-19 Genomics UK (COG-UK) consortium, , de Silva, T. I.
10.1101/2021.03.02.433156 — Posted: 2021-03-03
Low-dose lung radiotherapy for COVID-19 lung disease: a pre-clinical efficacy study in a bleomycin model of pneumonitis.
Jackson, M. R., Stevenson, K., Chahal, S. K., Curley, E., Finney, G., Gutierrez-Quintana, R., Onwubiko, E., Rupp, A. F., Strathdee, K., MacLeod, M. K., McSharry, C., Chalmers, A. J.
10.1101/2021.03.03.433704 — Posted: 2021-03-03
Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly
Credle, J. J., Gunn, J., Sangkhapreecha, P., Monaco, D. R., Zheng, X. A., Tsai, H.-J., Wilbon, A., Morgenlander, W. R., Dong, Y., Jayaraman, S., Tosi, L., Parekkadan, B., Baer, A. N., Roederer, M., Bloch, E. M., Tobian, A. A. R., Zyskind, I., Silverberg, J. I., Rosenberg, A. Z., Cox, A. L., Lloyd, T., Mammen, A. L., Larman, H. B.
10.1101/2021.03.02.432977 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).